1. Home
  2. ASPN vs LCTX Comparison

ASPN vs LCTX Comparison

Compare ASPN & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aspen Aerogels Inc.

ASPN

Aspen Aerogels Inc.

HOLD

Current Price

$4.76

Market Cap

363.8M

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.09

Market Cap

301.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPN
LCTX
Founded
2001
1990
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
363.8M
301.7M
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
ASPN
LCTX
Price
$4.76
$1.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$4.25
$6.25
AVG Volume (30 Days)
922.6K
1.0M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$271,103,000.00
$14,556,000.00
Revenue This Year
N/A
$109.40
Revenue Next Year
$50.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.24
52 Week Low
$2.30
$0.95
52 Week High
$9.78
$2.09

Technical Indicators

Market Signals
Indicator
ASPN
LCTX
Relative Strength Index (RSI) 44.62 40.41
Support Level $3.01 $1.00
Resistance Level $5.48 $1.32
Average True Range (ATR) 0.33 0.06
MACD -0.04 -0.00
Stochastic Oscillator 49.82 34.69

Price Performance

Historical Comparison
ASPN
LCTX

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: